NeuroMetrix Receives FDA 510(k) Clearance for Electrical Nerve Stimulator

NeuroMetrix has received FDA 510(k) approval for the SENSUS Pain Management Device intended for use as a transcutaneous electrical nerve stimulator for symptomatic relief and management of chronic intractable pain.

Advertisement

The company plans to launch the system during the fourth quarter of this year. It is designed for patients with diabetes for safe treatment of diabetic neuropathy.

More Articles on Pain Management:

Central Phoenix Surgical Center Adds Progenitor Cell Therapy

Tennessee Grants 255 Pain Clinics Licenses Since New Law

Indiana Senator to Sponsor Bill Requiring Pain Clinic Owners be Physicians

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.